Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Massachusetts Eye and Ear Infirmary: Clinical Trials & FDA Approval Profile

Massachusetts Eye and Ear Infirmary (Global / Institutional) sponsors 15 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 8 active protocols (6 recruiting now), 2 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)26.7%
Median Closed Enrollment vs National (145 pts)63 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Massachusetts Eye and Ear Infirmary
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)15
Active Pipeline (Recruiting Now)8 (6)
Completed vs Stopped Early2 / 4 (26.7%)
Median Closed Actual Enrollment63 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Massachusetts Eye and Ear Infirmary
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06753916ExCrossV Multi Site Trial for Vascularized High Risk KeratoplastyPhase IIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Massachusetts Eye and Ear Infirmary Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI